News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Warning: potential liver harm associated with Arthrem

PRIVILEGED STATEMENT

STATEMENT UNDER SECTION 98 OF THE MEDICINES ACT 1981 - Warning of potential harm to liver associated with the natural medicine Arthrem


19 February 2018


Medsafe is advising members of the public taking the dietary supplement Arthrem of a potential risk of harm to the liver.

Arthrem is marketed as a ‘dietary supplement used to relieve joint pain and stiffness.’

Arthrem is not an approved medicine, and Medsafe has become aware of 14 instances of harm to the liver (toxicity) among consumers who have taken Arthrem.

The Centre for Adverse Reactions Monitoring (CARM) received 20 notifications between February 2016 and 31 December 2017, 14 of which described harm to the liver.

“CARM has notified us that there is an ongoing issue with this product,” says Medsafe group manager Chris James.

“Medsafe wants to ensure all New Zealanders who are using this product are aware of the serious risk it may pose. In some of the cases reported to CARM the patient required hospital care.”

All 14 patients have stopped taking Arthrem, and have since either recovered or are improving.

If anyone taking Arthrem has any of the following symptoms, they are advised to stop taking Arthrem and contact their doctor. The symptoms are:

· nausea (feeling sick)
· stomach pain
· pale stools
· dark urine
· itching all-over
· the whites of the eyes have turned yellow or the skin is yellow (jaundice)

“Liver toxicity, including hepatitis, abnormal liver function and jaundice, has been reported in patients taking Arthrem,” says Mr James.

“As the chemical composition of the Artemisia annuaextract is not disclosed, it is possible other products containing Artemisia annuaextract may have similar effects. If you are using a product containing Artemisia annuaextract and develop any of those symptoms, the advice is the same: stop taking the product and seek medical advice.”

Medsafe is continuing to monitor the safety of Arthrem.

More information, including how to report an adverse event to CARM, is available on the Medsafe website: http://www.medsafe.govt.nz/safety/EWS/2018/Arthrem.asp

BACKGROUND:
This product is not being recalled by Medsafe. It is not currently an approved medicine Anyone using Arthrem is advised to monitor their own health, and if they have any concerns, discuss these with their medical practitioner.

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Facebook Announces New Changes: Combating Hate And Extremism

Some of these changes predate the tragic terrorist attack in Christchurch, New Zealand, but that attack, and the global response to it in the form of the Christchurch Call to Action, has strongly influenced the recent updates to our policies and their enforcement. More>>

Amazon Confirms: Lord Of The Rings Series To Shoot In NZ

Amazon Studios announced today that its series based on J.R.R. Tolkien’s iconic fantasy novels The Lord of the Rings will shoot in New Zealand. Pre-production has started, and production on the series will begin in Auckland in the coming months. More>>

ALSO:

Birds: Dunedin's Bells Ring As City Celebrates Its Albatross

The city's churches, schools and public buildings bells would chime in unison from 1pm, in what has been a long-standing tradition marking the return of the birds - and a farewell to this season's albatross chicks. More>>

Oscar Buzz: Waititi's Jojo Rabbit Wins People's Choice Award At Toronto

Taika Waititi's new film Jojo Rabbit has nabbed the coveted Grolsch People's Choice Award at the close of Toronto International Film Festival. More>>

ALSO:

Broken Estate: An Expat Expert Surveys Our Media

Melanie Bunce cut her teeth in journalism at the Otago Daily Times. Now she teaches and researches it at one of the UK’s most prestigious journalism schools and tracks the trends that shape the uncertain future of news... More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland